NICE says that patients' age should affect treatment
BMJ 2005; 330 doi: https://doi.org/10.1136/bmj.330.7500.1102-a (Published 12 May 2005) Cite this as: BMJ 2005;330:1102Data supplement
NICE says patients’ age should be considered in healthcare decisions
London
Susan Mayor
The age of patients should be considered in assessing the potential benefits and risks of healthcare interventions, according to a consultation document from the National Institute for Health and Clinical Excellence (NICE), which advises on the use of treatments in the NHS in England and Wales.
The consultation report was designed to clarify the social value judgements—defined as ethical principles, preferences, culture, and aspirations—that should be used by NICE in conjunction with clinical judgments in deciding what the NHS should provide.
The report proposed that age should be taken into account when NICE is making decisions. It said: “Where age is an indicator of benefit or risk, age discrimination may be appropriate.” However, it recommended that health should not be valued more highly in some age groups than in others and that individuals’ social roles at different ages should not influence considerations of cost effectiveness.
The report also said that sex or sexual orientation should not be taken into account unless these were relevant to benefits, risks, or both. It also recommended that discrimination against patients with conditions that were self inflicted should be avoided, unless they might influence the likely outcome of an intervention.
The recommendations were based on a review of relevant published literature, reports from NICE’s Citizens Council (30 people who reflect the age, sex, socioeconomic status, and ethnicity of the population in England and Wales) and a survey of 1010 members of the public.
Andrew Dillon, chief executive of NICE, explained the need for the consultation: “The institute has to make difficult decisions about how well treatments work and which treatments offer the NHS best value for money. We know that factors such as age and lifestyle can influence how clinically or cost effective a treatment is, and we are asking people whether NICE is getting it right when we take this type of factor into account during the development of our guidance.”
Mr Dillon noted that NICE had made judgments in the past that took age into account, with the balance of risk versus benefit in favour of recommending health interventions in older people rather than younger people in some situations. For example, NICE recommended that drug treatments for flu should be made available for people aged over 65 as they are a vulnerable group and likely to be more seriously affected by flu than younger people. In other situations, on the other hand, interventions may have a greater ratio of benefit to risk in younger people. The NICE guideline on fertility treatment recommended that in vitro fertilisation be made available to women aged 23-39 years as it was most likely to be effective in this age range.
The suggestion that age should be considered in decision making by NICE was criticised by groups representing elderly people. Jonathan Ellis, policy manager for health and social care with Help the Aged, said: “To suggest that anyone should receive less care and attention simply because they happen to be older is blatant discrimination. It also runs contrary to the government’s stated aim of tackling the prejudice against older people that exists in health care services.”
He said that Help the Aged would, in the NICE consultation process, be urging the adoption of “guidelines that stress the importance of treatment on the basis of need rather than age.” The consultation period closes on 30 June, and the guidelines will then be revised before the final version is published.
In addition to raising the issue of age, the consultation document reiterated NICE’s commitment to assessing cost effectiveness, noting: “For both legal and bioethical reasons those undertaking technology appraisals and developing clinical guidelines must take account of economic considerations.” It also recommended that special consideration be given to innovations that provide major improvements in health for previously untreatable conditions but that take account of the prognosis, the magnitude of the gain in health, and the cost.
Details on NICE’s consultation on social judgment, as well as its guidance on flu treatments and fertility treatment, can be found www.nice.org.uk
See more
- Evidence review ordered by government backs minimum alcohol pricingBMJ December 05, 2016, 355 i6546; DOI: https://doi.org/10.1136/bmj.i6546
- Woman denied abortion in Ireland is offered €30 000 compensationBMJ December 05, 2016, 355 i6530; DOI: https://doi.org/10.1136/bmj.i6530
- Communicating risk to patients in the emergency departmentBMJ December 05, 2016, 355 i6437; DOI: https://doi.org/10.1136/bmj.i6437
- The future of NHS dentistry in ScotlandBMJ December 05, 2016, 355 i6466; DOI: https://doi.org/10.1136/bmj.i6466
- The Association of Cancer Physicians responds to “Cancer drugs, survival, and ethics”BMJ December 05, 2016, 355 i6487; DOI: https://doi.org/10.1136/bmj.i6487
Cited by...
- Too old to treat?